Answers are grounded in this paper and cite their sources.
Randomized trial reports the design of peritoneal ultrafiltration with PolyCore in refractory congestive heart failure, highlighting a novel fluid removal approach.
Peritoneal ultrafiltration (PUF) has been proposed as an additional therapeutic option for refractory congestive heart failure (RCHF) patients. Despite promising observational studies and/or case report results, limited clinical trial data exist, and so far, PUF solutions remain only indicated for chronic kidney diseases. In this article, we described a multicenter, randomized, controlled, unblinded, adaptive design clinical trial, about to start, investigating the effects of PolyCore™, an innovative PUF solution, in the treatment of RCHF patients.
No takes yet. Share an insight, caveat, or question.
Gronda et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: